The Effects of TWEAK, Fn14, and TGF-beta1 on Degeneration of Human Intervertebral Disc

Hoon Huh1, Yong-Jik Lee, Jung-Hee Kim

  • 1Department of Neurosurgery, Medical Institute, Seoul Medical Center, Seoul, Korea.

Abstract

Insights

Tumor necrosis factor (TNF) like weak inducer of apoptosis (TWEAK) significantly decreases sulfated glycosaminoglycan (sGAG) and key gene expression in human intervertebral disc (IVD) degeneration. Fibroblast growth factor-inducible 14 (Fn14) and transforming growth factor-beta1 (TGF-beta1) partially counteract TWEAK's effects.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Biomedical Engineering

Background:

  • Intervertebral disc (IVD) degeneration is a complex process.
  • The roles of specific molecular mediators like TWEAK, Fn14, and TGF-beta1 in IVD degeneration require further elucidation.

Purpose of the Study:

  • To investigate the effects of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK), fibroblast growth factor-inducible 14 (Fn14), and transforming growth factor-beta1 (TGF-beta1) on human IVD degeneration.
  • To understand the reciprocal actions of these factors in modulating IVD cellular and matrix components.

Main Methods:

  • Human IVD tissues and cells were cultured in vitro.
  • Levels of sulfated glycosaminoglycan (sGAG) were measured using dimethyl methyleneblue (DMMB) assay.
  • Messenger RNA (mRNA) levels of sex determining region Y (SRY)-box 9 (Sox9) and versican were quantified via reverse transcriptase polymerase chain reaction (RT-PCR).

Main Results:

  • TWEAK significantly decreased sGAG content and mRNA levels of versican and Sox9 in IVD tissues.
  • TGF-beta1 increased sGAG concentration and Sox9 mRNA expression.
  • Fn14 did not significantly alter sGAG production but showed a trend towards increasing sGAG and gene expression when combined with TGF-beta1.

Conclusions:

  • TWEAK plays a role in intervertebral disc degeneration by reducing sGAG and key matrix gene expression.
  • TGF-beta1 may have protective effects, partially counteracting TWEAK-induced degeneration.
  • Further research is needed to fully understand the therapeutic potential of modulating these pathways in IVD disorders.

Related Concept Videos

Degenerative Disc Disease I: Introduction01:27

Degenerative Disc Disease I: Introduction

Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
Degenerative Disc Disease ll: Pathophysiology01:23

Degenerative Disc Disease ll: Pathophysiology

The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
Herniated Intervertebral Disc l: Introduction01:29

Herniated Intervertebral Disc l: Introduction

Intervertebral disc herniation refers to the displacement of the nucleus pulposus (the gel-like inner core of the disc) through a tear or weakened area in the annulus fibrosus (the outer fibrous ring). The displaced disc material extends beyond the normal boundaries of the disc space and may compress or irritate nearby spinal nerve roots or, less commonly, the spinal cord.Etiology and Risk FactorsHerniation commonly results from degeneration, in which aging reduces disc hydration and...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...